Full Text Available
Note: Clicking the button above will open the full text document at the original institutional repository in a new window.
Platelet caspase‐1 and Bruton tyrosine kinase activation in patients with COVID‐19 is associated with disease severity and reversed in vitro by ibrutinib
Saved in:
| Published in: | Research and Practice in Thrombosis and Haemostasis |
|---|---|
| Format: | Online Article RSS Article |
| Published: |
2022
|
| Subjects: | |
| Tags: |
No Tags, Be the first to tag this record!
|
| _version_ | 1868552916337426432 |
|---|---|
| collection | WordPress RSS FRELIP Feed Integration |
| container_title | Research and Practice in Thrombosis and Haemostasis |
| description | |
| discipline_display | Internal Medicine |
| discipline_facet | Internal Medicine |
| format | Online Article RSS Article |
| genre | Journal Article |
| id | rss_article:67992 |
| institution | FRELIP |
| journal_source_facet | Research and Practice in Thrombosis and Haemostasis |
| last_indexed | 2026-06-20T21:28:40.759Z |
| publishDate | 2022 |
| publishDateSort | 2022 |
| record_format | rss_article |
| spellingShingle | Platelet caspase‐1 and Bruton tyrosine kinase activation in patients with COVID‐19 is associated with disease severity and reversed in vitro by ibrutinib Internal Medicine General Internal Medicine |
| sub_discipline_display | General |
| sub_discipline_facet | General |
| subject_display | Internal Medicine General Internal Medicine |
| subject_facet | Internal Medicine General Internal Medicine |
| title | Platelet caspase‐1 and Bruton tyrosine kinase activation in patients with COVID‐19 is associated with disease severity and reversed in vitro by ibrutinib |
| title_alt | La activación de caspasa-1 plaquetaria y tirosina quinasa de Bruton en pacientes con COVID-19 se asocia con la gravedad de la enfermedad y se revierte in vitro con ibrutinib L'activation de la caspase-1 plaquettaire et de la tyrosine kinase de Bruton chez les patients atteints de COVID-19 est associée à la sévérité de la maladie et inversée in vitro par l'ibrutinib Ativação de caspase-1 plaquetária e tirosina quinase de Bruton em pacientes com COVID-19 está associada à gravidade da doença e revertida in vitro por ibrutinibe |
| title_auth | Platelet caspase‐1 and Bruton tyrosine kinase activation in patients with COVID‐19 is associated with disease severity and reversed in vitro by ibrutinib |
| title_es_txt | La activación de caspasa-1 plaquetaria y tirosina quinasa de Bruton en pacientes con COVID-19 se asocia con la gravedad de la enfermedad y se revierte in vitro con ibrutinib |
| title_fr_txt | L'activation de la caspase-1 plaquettaire et de la tyrosine kinase de Bruton chez les patients atteints de COVID-19 est associée à la sévérité de la maladie et inversée in vitro par l'ibrutinib |
| title_full | Platelet caspase‐1 and Bruton tyrosine kinase activation in patients with COVID‐19 is associated with disease severity and reversed in vitro by ibrutinib |
| title_fullStr | Platelet caspase‐1 and Bruton tyrosine kinase activation in patients with COVID‐19 is associated with disease severity and reversed in vitro by ibrutinib |
| title_full_unstemmed | Platelet caspase‐1 and Bruton tyrosine kinase activation in patients with COVID‐19 is associated with disease severity and reversed in vitro by ibrutinib |
| title_pt_txt | Ativação de caspase-1 plaquetária e tirosina quinase de Bruton em pacientes com COVID-19 está associada à gravidade da doença e revertida in vitro por ibrutinibe |
| title_short | Platelet caspase‐1 and Bruton tyrosine kinase activation in patients with COVID‐19 is associated with disease severity and reversed in vitro by ibrutinib |
| title_sort | platelet caspase‐1 and bruton tyrosine kinase activation in patients with covid‐19 is associated with disease severity and reversed in vitro by ibrutinib |
| topic | Internal Medicine General Internal Medicine |
| url | https://onlinelibrary.wiley.com/doi/10.1002/rth2.12811?af=R |